Healthcare & Life Sciences
Monte Rosa Therapeutics
United Stateswww.monterosatx.com/
aliveseries-c-plus
series-c-plus
Stage
2018
Founded
3
Investors
About
Monte Rosa Therapeutics is a clinical-stage biotech company developing molecular glue degraders that use AI, proteomics, structural biology, and chemistry to target proteins for degradation in oncology and immunology diseases.
Explore Monte Rosa Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.